AR020851A2 - Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos - Google Patents
Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentosInfo
- Publication number
- AR020851A2 AR020851A2 ARP990106063A ARP990106063A AR020851A2 AR 020851 A2 AR020851 A2 AR 020851A2 AR P990106063 A ARP990106063 A AR P990106063A AR P990106063 A ARP990106063 A AR P990106063A AR 020851 A2 AR020851 A2 AR 020851A2
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- groups
- group
- optionally substituted
- halogen atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
Abstract
Un compuesto de formula (1) o una de sus sales farmacéuticamente aceptables, en la que: R1 es un grupo alquilo, alquenilo, alquinilo, alcoxialquilo oalquiltioalquilo C3-8 alfa ramificado, pudiendo estar en cualquiera de los cuales opcionalmente sustituido por uno o más grupos hidroxilo; un grupocicloalquilalquilo C5-8 en el que el grupo alquilo es un grupo alquilo C2-5 alfa ramificado; un grupo cicloalquilo C3-8 cicloalquenilo C5-8, cualquiera de loscuales puede estar opcionalmente sustituido por metilo o uno o más hidroxilo o uno o más grupos alquilo C1-4 o átomos de halogeno; o un anillo heterocíclicoque contiene oxígeno o azufre de 3 a 6 eslabones que puede ser saturado o, total o parcialmente insaturado y que puede estar opcionalmente sustituido por uno omás grupos alquilo C1-4 o átomos de halogeno; o R1 es fenilo que puede estar opcionalmente sustituido con al menos un sustituyente seleccionado de gruposalquilo C1-4, alcoxi C1-4 y (alquil C1-4)tio, átomos de halogeno, grupos hidroxilo, trifluorometilo y ciano; o R1 puede ser un grupo con una fomula (a) en laque X es O, S o -CH2-,a b, c, y d son cada uno, independientemente, 0-2 y a+b+c+d < o = 5; o R1 es CH2R24, donde R24 es H, alquilo C1-6, alquenilo C2-6,alquinilo C2-6, alcoxialquilo o alquiltioalquilo, que contienen de 1 a 6 átomos de carbono en cada uno de los grupos alquilo o alcoxi, pudiendo estarcualquiera de dichos grupos alquilo, alcoxi, alquenilo o alquinilo sustituido por uno o más grupos hidroxilo o por uno omás átomos de halogeno; o uncicloalquilo C3-6 o cicloalquenilo C3-6, cualquiera de los cuales puede estar opcionalmente sustituido por metilo o uno o más grupos alquilo C1-4 o átomos dehalogeno; o un anillo heterocíclico que contiene oxígeno o azufre de 3 a 6 eslabones que puede ser saturado o total o parcialmente insaturado y puede estaropcionalmente sustituido por uno o más grupos alquilo C1-4, o átomos de halogeno; o un grupo de formula SR23, donde R23 es alquilo C1-6, alquenilo C2-6,alquinilo C2-6, cicloalquilo C3-6, cicloalquenilo C3-6, fenilo o fenilo sustituido, donde el sustituyente es alquilo C1-4, alcoxi C1-4 o halogeno, o un anillo
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7034398P | 1998-01-02 | 1998-01-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR020851A2 true AR020851A2 (es) | 2002-05-29 |
Family
ID=22094723
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980106717A AR014948A1 (es) | 1998-01-02 | 1998-12-29 | Compuestos macrolidos, composiciones, su uso para la manufactura de medicamentos y metodo para prepararlos. |
| ARP990106063A AR020851A2 (es) | 1998-01-02 | 1999-11-29 | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos |
| ARP990106062A AR019787A2 (es) | 1998-01-02 | 1999-11-29 | Compuestos macrolidos, su uso en la preparacion de medicamentos, composiciones y metodo para la preparacion de los mismos |
| ARP990106064A AR020551A2 (es) | 1998-01-02 | 1999-11-29 | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980106717A AR014948A1 (es) | 1998-01-02 | 1998-12-29 | Compuestos macrolidos, composiciones, su uso para la manufactura de medicamentos y metodo para prepararlos. |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP990106062A AR019787A2 (es) | 1998-01-02 | 1999-11-29 | Compuestos macrolidos, su uso en la preparacion de medicamentos, composiciones y metodo para la preparacion de los mismos |
| ARP990106064A AR020551A2 (es) | 1998-01-02 | 1999-11-29 | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos. |
Country Status (34)
| Country | Link |
|---|---|
| US (2) | US6472371B1 (es) |
| EP (1) | EP1044207A1 (es) |
| JP (1) | JP2002500230A (es) |
| KR (1) | KR100352809B1 (es) |
| CN (1) | CN1284081A (es) |
| AP (1) | AP9801420A0 (es) |
| AR (4) | AR014948A1 (es) |
| AU (1) | AU756409B2 (es) |
| BG (1) | BG104644A (es) |
| BR (1) | BR9814601A (es) |
| CA (1) | CA2316919C (es) |
| CO (1) | CO4970821A1 (es) |
| CZ (1) | CZ20002458A3 (es) |
| DZ (1) | DZ2698A1 (es) |
| EA (1) | EA200000594A1 (es) |
| GT (1) | GT199800206A (es) |
| HR (1) | HRP20000442A2 (es) |
| HU (1) | HUP0100420A3 (es) |
| IL (1) | IL137024A0 (es) |
| IS (1) | IS5528A (es) |
| MA (1) | MA24729A1 (es) |
| NO (1) | NO20003347L (es) |
| NZ (1) | NZ504986A (es) |
| OA (1) | OA11438A (es) |
| PA (1) | PA8465301A1 (es) |
| PE (1) | PE20000049A1 (es) |
| PL (1) | PL341642A1 (es) |
| SK (1) | SK9782000A3 (es) |
| TN (1) | TNSN98238A1 (es) |
| TW (1) | TW520374B (es) |
| UY (2) | UY25330A1 (es) |
| WO (1) | WO1999035156A1 (es) |
| YU (1) | YU41500A (es) |
| ZA (1) | ZA9811939B (es) |
Families Citing this family (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
| AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| US6043227A (en) * | 1998-08-19 | 2000-03-28 | Pfizer Inc. | C11 carbamates of macrolide antibacterials |
| EP1437360A3 (en) * | 1998-08-19 | 2005-04-06 | Pfizer Products Inc. | C11 Carbamates of macrolide antibacterials |
| EP1754700A3 (en) | 1999-01-27 | 2007-05-09 | Kosan Biosciences, Inc. | Synthesis of oligoketides |
| US6590083B1 (en) | 1999-04-16 | 2003-07-08 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| WO2000062783A2 (en) | 1999-04-16 | 2000-10-26 | Ortho-Mcneil Pharmaceutical, Inc. | Ketolide antibacterials |
| US6451768B1 (en) | 1999-04-16 | 2002-09-17 | Kosan Biosciences, Inc. | Macrolide antiinfective agents |
| HUP0201516A3 (en) | 1999-05-24 | 2003-03-28 | Pfizer Prod Inc | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them |
| US20050209446A1 (en) * | 2002-02-26 | 2005-09-22 | Meiji Seika Kaisha Ltd. | Novel 15-membered cyclic azalide, novel 16-membered cyclic diazalide derivative, and process for producing these |
| EP1799636B1 (en) | 2004-09-23 | 2008-08-27 | Schering-Plough Ltd. | Control of parasites in animals by the use of novel trifluoromethanesulfonanilide oxime ether derivatives |
| US7705038B2 (en) * | 2004-11-19 | 2010-04-27 | Intervet, Inc. | Control of parasites in animals by the use of parasiticidal 2-phenyl-3-(1H-pyrrol-2-yl)acrylonitrile derivatives |
| AU2005317735B2 (en) | 2004-12-21 | 2009-06-04 | Pfizer Products Inc. | Macrolides |
| CA2609574A1 (en) * | 2005-06-09 | 2006-12-21 | Schering-Plough Ltd. | Control of parasites in animals by n-[(phenyloxy)phenyl]-1,1,1-trifluoromethanesulfonamide and n-[(phenylsulfanyl)phenyl]-1,1,1-trifluoromethanesulfonamide derivatives |
| US8119667B2 (en) * | 2005-12-29 | 2012-02-21 | Schering-Plough Animal Health Corporation | Carbonates of fenicol antibiotics |
| US20070238700A1 (en) * | 2006-04-10 | 2007-10-11 | Winzenberg Kevin N | N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites |
| MX2009006467A (es) * | 2006-12-13 | 2009-08-21 | Schering Plough Ltd | Profarmacos solubles en agua de cloranfenicol, tiamfenicol y analogos de los mismos. |
| WO2008076259A1 (en) * | 2006-12-13 | 2008-06-26 | Schering-Plough Ltd. | Water-soluble prodrugs of florfenicol and its analogs |
| TWI430995B (zh) | 2007-06-26 | 2014-03-21 | Du Pont | 萘異唑啉無脊椎有害動物控制劑 |
| MX368680B (es) | 2007-06-27 | 2019-10-11 | Du Pont | Administración subcutánea de un derivado de isoxazol-benzamida para usarse en un método para proteger un mamífero de una pulga. |
| US20090131343A1 (en) * | 2007-11-15 | 2009-05-21 | Ly Tam Phan | Use of bridged macrolides or tylosin derivatives in treating inflammatory bowel diseases |
| TWI401023B (zh) | 2008-02-06 | 2013-07-11 | Du Pont | 中離子農藥 |
| WO2010014566A2 (en) * | 2008-07-30 | 2010-02-04 | Intervet International B.V. | Process for preparing oxazoline-protected aminodiol compounds useful as intermediates to florfenicol |
| JP2013501059A (ja) | 2009-08-05 | 2013-01-10 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | メソイオン性殺虫剤 |
| UA107804C2 (en) | 2009-08-05 | 2015-02-25 | Du Pont | Mixtures of pesticides mezoionnyh |
| UA110924C2 (uk) | 2009-08-05 | 2016-03-10 | Е. І. Дю Пон Де Немур Енд Компані | Мезоіонні пестициди |
| MX2012001646A (es) | 2009-08-05 | 2012-03-21 | Du Pont | Pesticidas mesoionicos. |
| CA2799963C (en) | 2010-05-27 | 2018-01-23 | E. I. Du Pont De Nemours And Company | Crystalline form of 4- [5 - [3 -chloro-5 - (trifluoromethyl) phenyl] -4,5 -dihydro-5 - (trifluoromethyl) -3 - isoxazolyl] -n- [2-0x0-2- [(2,2,2-trifluoroethyl)amino]ethyl] -1-naphthalenecarboxamide |
| WO2012087630A1 (en) | 2010-12-20 | 2012-06-28 | E.I. Du Pont De Nemours And Company | Pyridine and pyrimidine compounds for controlling invertebrate |
| KR20140004187A (ko) * | 2011-01-31 | 2014-01-10 | 메이지 세이카 파루마 가부시키가이샤 | 신규 마크로라이드 유도체 |
| AU2012273133A1 (en) | 2011-06-20 | 2013-11-07 | E. I. Du Pont De Nemours And Company | Heterocyclic compounds for treating helminth infections |
| CN102260306B (zh) * | 2011-07-22 | 2012-07-18 | 山东鲁抗舍里乐药业有限公司 | 一种制备泰拉霉素的方法 |
| AU2012346433A1 (en) | 2011-11-28 | 2014-05-08 | E. I. Du Pont De Nemours And Company | N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics |
| WO2013158422A1 (en) | 2012-04-17 | 2013-10-24 | E. I. Du Pont De Nemours And Company | Heterocyclic compounds for controlling invertebrate pests |
| WO2014099837A1 (en) | 2012-12-18 | 2014-06-26 | E. I. Du Pont De Nemours And Company | Sulfonamide anthelmintics |
| CN103965273B (zh) * | 2013-08-23 | 2016-05-25 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
| CN105669798B (zh) * | 2013-08-23 | 2019-07-26 | 普莱柯生物工程股份有限公司 | 一种大环内酯类化合物 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3652537A (en) * | 1969-11-21 | 1972-03-28 | Lilly Co Eli | Epierythromycylamine and epierythromycyl b amine |
| US3923784A (en) * | 1973-09-10 | 1975-12-02 | Hoffmann La Roche | Erythromycin a derivatives |
| SI7910768A8 (en) * | 1979-04-02 | 1996-06-30 | Pliva Pharm & Chem Works | Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives |
| US4474768A (en) * | 1982-07-19 | 1984-10-02 | Pfizer Inc. | N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor |
| US4585759A (en) * | 1985-01-22 | 1986-04-29 | Pfizer Inc. | Antibacterial derivatives of a neutral macrolide |
| DE3860503D1 (de) * | 1987-09-03 | 1990-10-04 | Pliva Pharm & Chem Works | 10-dihydro-10-deoxo-11-azaerythronolid-a-verbindungen,verfahren und zwischenprodukte zu ihrer herstellung und ihre verwendung in arzneimitteln und in deren herstellung. |
| US5141926A (en) * | 1990-04-18 | 1992-08-25 | Abbott Laboratories | Erythromycin derivatives |
| WO1993013663A1 (en) | 1992-01-17 | 1993-07-22 | Abbott Laboratories | Method of directing biosynthesis of specific polyketides |
| US5824513A (en) * | 1991-01-17 | 1998-10-20 | Abbott Laboratories | Recombinant DNA method for producing erythromycin analogs |
| US5985844A (en) * | 1992-03-26 | 1999-11-16 | Merck & Co., Inc. | Homoerythromycin A derivatives modified at the 4"-and 8A-positions |
| CA2065218A1 (en) | 1991-04-11 | 1992-10-12 | Robert R. Wilkening | Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives |
| US5523399A (en) * | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
| FR2691464B1 (fr) * | 1992-05-21 | 1995-06-02 | Roussel Uclaf | Nouveaux dérivés de la 1-oxa 6-azacyclopentadécane 13,15-dione, leur procédé de préparation et leur application comme médicaments. |
| US5332807A (en) * | 1993-04-14 | 1994-07-26 | Merck & Co., Inc. | Process of producing 8A- and 9A-azalide antibiotics |
| US5441939A (en) * | 1994-03-04 | 1995-08-15 | Pfizer Inc. | 3"-desmethoxy derivatives of erythromycin and azithromycin |
| US6271255B1 (en) * | 1996-07-05 | 2001-08-07 | Biotica Technology Limited | Erythromycins and process for their preparation |
| AU6932098A (en) * | 1997-05-09 | 1998-12-08 | Pfizer Products Inc. | Erythromycin derivatives |
| HN1998000074A (es) * | 1997-06-11 | 1999-01-08 | Pfizer Prod Inc | Derivados de macrolidos c-4 sustituidos |
| HN1998000086A (es) * | 1997-06-11 | 1999-03-08 | Pfizer Prod Inc | Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos. |
| US6407074B1 (en) * | 1997-06-11 | 2002-06-18 | Pfizer Inc | C-4″-substituted macrolide derivatives |
| US20020025937A1 (en) * | 2000-03-20 | 2002-02-28 | Yong-Jin Wu | 9-oxime erythromycin derivatives |
| AU7961498A (en) | 1997-06-26 | 1999-01-19 | Merck & Co., Inc. | 9a-azalides, compositions containing such compounds and methods of treatment |
| US6339063B1 (en) * | 1997-09-10 | 2002-01-15 | Merck & Co., Inc. | 9a-azalides as veterinary antimicrobial agents |
| HN1998000159A (es) * | 1997-10-29 | 1999-02-09 | Monsanto Co | Derivados de 9- amino - 3 ceto eritromicina |
| PA8461401A1 (es) * | 1997-10-29 | 2000-05-24 | Pfizer Prod Inc | Derivados de eritromicina triciclicos |
| AP9801420A0 (en) | 1998-01-02 | 1998-12-31 | Pfizer Prod Inc | Novel macrolides. |
| AP1060A (en) | 1998-01-02 | 2002-04-23 | Pfizer Prod Inc | Novel erythromycin derivatives. |
| ATE275151T1 (de) * | 1998-03-03 | 2004-09-15 | Pfizer Prod Inc | 3,6-ketal-makrolidantibiotika |
| US6248719B1 (en) * | 1998-06-03 | 2001-06-19 | Pfizer Inc | Tricyclic 3-keto derivatives of 6-O-methylerthromycin |
| US6043227A (en) * | 1998-08-19 | 2000-03-28 | Pfizer Inc. | C11 carbamates of macrolide antibacterials |
| US6100240A (en) * | 1998-10-09 | 2000-08-08 | Pfizer Inc | Macrolide derivatives |
| AU5995299A (en) * | 1998-11-03 | 2000-05-22 | Pfizer Products Inc. | Novel macrolide antibiotics |
| UA70972C2 (uk) * | 1998-11-20 | 2004-11-15 | Пфайзер Продактс Інк. | 13-членні азаліди і їх застосування як антибіотиків |
| HUP0201516A3 (en) | 1999-05-24 | 2003-03-28 | Pfizer Prod Inc | 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them |
| EP1101769A3 (en) * | 1999-11-18 | 2001-10-24 | Pfizer Products Inc. | Nitrogen containing erythromycin derivatives |
| WO2003014136A1 (en) | 2001-08-08 | 2003-02-20 | Taisho Pharmaceutical Co., Ltd. | 11a-AZALIDE COMPOUNDS AND PROCESS FOR PRODUCING THE SAME |
-
1998
- 1998-12-17 AP APAP/P/1998/001420A patent/AP9801420A0/en unknown
- 1998-12-21 NZ NZ504986A patent/NZ504986A/xx unknown
- 1998-12-21 AU AU14447/99A patent/AU756409B2/en not_active Ceased
- 1998-12-21 JP JP2000527552A patent/JP2002500230A/ja active Pending
- 1998-12-21 US US09/554,988 patent/US6472371B1/en not_active Expired - Fee Related
- 1998-12-21 CZ CZ20002458A patent/CZ20002458A3/cs unknown
- 1998-12-21 HU HU0100420A patent/HUP0100420A3/hu unknown
- 1998-12-21 EP EP98958384A patent/EP1044207A1/en not_active Withdrawn
- 1998-12-21 BR BR9814601-7A patent/BR9814601A/pt not_active IP Right Cessation
- 1998-12-21 PL PL98341642A patent/PL341642A1/xx unknown
- 1998-12-21 YU YU41500A patent/YU41500A/sh unknown
- 1998-12-21 CA CA002316919A patent/CA2316919C/en not_active Expired - Fee Related
- 1998-12-21 CN CN98813253A patent/CN1284081A/zh active Pending
- 1998-12-21 IL IL13702498A patent/IL137024A0/xx unknown
- 1998-12-21 SK SK978-2000A patent/SK9782000A3/sk unknown
- 1998-12-21 KR KR1020007007313A patent/KR100352809B1/ko not_active IP Right Cessation
- 1998-12-21 WO PCT/IB1998/002099 patent/WO1999035156A1/en not_active Application Discontinuation
- 1998-12-22 EA EA200000594A patent/EA200000594A1/ru unknown
- 1998-12-23 PA PA19988465301A patent/PA8465301A1/es unknown
- 1998-12-23 TW TW087121542A patent/TW520374B/zh not_active IP Right Cessation
- 1998-12-28 PE PE1998001287A patent/PE20000049A1/es not_active Application Discontinuation
- 1998-12-29 GT GT199800206A patent/GT199800206A/es unknown
- 1998-12-29 AR ARP980106717A patent/AR014948A1/es not_active Application Discontinuation
- 1998-12-30 ZA ZA9811939A patent/ZA9811939B/xx unknown
- 1998-12-30 DZ DZ980308A patent/DZ2698A1/xx active
- 1998-12-30 TN TNTNSN98238A patent/TNSN98238A1/fr unknown
- 1998-12-30 CO CO98077585A patent/CO4970821A1/es unknown
- 1998-12-30 MA MA25407A patent/MA24729A1/fr unknown
- 1998-12-30 UY UY25330A patent/UY25330A1/es not_active Application Discontinuation
-
1999
- 1999-06-18 UY UY25574A patent/UY25574A1/es not_active Application Discontinuation
- 1999-11-29 AR ARP990106063A patent/AR020851A2/es not_active Application Discontinuation
- 1999-11-29 AR ARP990106062A patent/AR019787A2/es not_active Application Discontinuation
- 1999-11-29 AR ARP990106064A patent/AR020551A2/es not_active Application Discontinuation
-
2000
- 2000-06-09 IS IS5528A patent/IS5528A/is unknown
- 2000-06-27 NO NO20003347A patent/NO20003347L/no unknown
- 2000-06-30 OA OA1200000192A patent/OA11438A/en unknown
- 2000-06-30 HR HR20000442A patent/HRP20000442A2/hr not_active Application Discontinuation
- 2000-07-28 BG BG104644A patent/BG104644A/xx unknown
-
2002
- 2002-07-30 US US10/209,682 patent/US7015203B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR020851A2 (es) | Compuestos macrolidos, composiciones y su uso para la preparacion de medicamentos | |
| AR020016A2 (es) | Compuestos derivados de la eritromicina, composiciones que los contienen, uso de los mismos para preparar un medicamento | |
| NO2022019I1 (no) | Eribulin eller et farmasøytisk akseptabelt salt derav - forlenget SPC | |
| AR065937A2 (es) | Compuesto derivado indazol, composicion farmaceutica que lo comprende y su uso en la fabricacion de medicamentos para modular la actividad de proteina quinasa | |
| UY27336A1 (es) | Derivados de 4-piperacinilindol con afinidad receptora de 5-ht6 | |
| ES2061204T3 (es) | Nuevos derivados de la amino-piperidina, de la amino-pirrolidina y de la amino-perhidroacepina, procedimientos de preparacion y composiciones farmaceuticas que los contienen. | |
| BR0111754A (pt) | Uso de um composto, método para inibir aurora 2 quinase em um animal de sangue quente, composto, e, composição farmacêutica | |
| AR037901A1 (es) | Beta-amino-alfa-cianoacrilatos | |
| AR055150A1 (es) | Compuestos de isoindol - imido y composiciones que los comprenden y sus metodos de uso | |
| ECSP034865A (es) | Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas | |
| KR930700490A (ko) | 탄산탈수효소 억제제로서 유용한 티오펜 설폰아미드 | |
| UY26727A1 (es) | Derivados de tropano útiles en terapia | |
| AR054560A1 (es) | Espiropiperidina como inhibidores de beta-secretasa para el tratamiento de la enfermedad de alzheimer | |
| AR043111A1 (es) | Derivados monoacilados de o-fenilendiaminas | |
| UY28848A1 (es) | Antagonistas de cgrp seleccionados, procedimientos para su preparación, y su empleo como medicamentos | |
| PE20071251A1 (es) | Derivados de benzo-heteroaril sulfamida para el tratamiento del dolor | |
| PE20061318A1 (es) | Nuevas combinaciones terapeuticas para el tratamiento o la prevencion de trastornos psicoticos | |
| AR020165A1 (es) | Derivados de pirimidinas sustituidas, su procedimiento de preparacion, composiciones farmaceuticas que las contienen y el uso de los mismos para la preparacion de medicamentos | |
| AR032466A1 (es) | Ciclilamina sulfonamidas, utilizacion de las mismas para la manufactura de un medicamento y composiciones farmaceuticas utiles como agonistas de los receptores beta-3 adrenergicos | |
| AR041395A1 (es) | Compuesto de piridina composicion farmaceutica que lo comprende y su uso para prepararla | |
| RS53389B (en) | PHARMACEUTICAL UNITS | |
| AR066954A1 (es) | Derivados de 7- alquinil-1,8- naftiridonas , su preparacion y su aplicacion en terapeutica | |
| AR044662A1 (es) | Compuestos de azetidina | |
| AR057005A1 (es) | Derivados de 4-fenil-5-oxo-1,4,5,6,7,8-hexahidroquinolina, una composicion farmaceutica y uso del compuesto para preparar un medicamento | |
| AR058257A1 (es) | Derivados de 8-azabiciclo[3.2.1]octano. composiciones farmaceuticas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |